Citigroup’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $281M | Buy |
572,177
+35,391
| +7% | +$19.2M | 0.12% | 162 |
|
|
2025
Q4 | $311M | Sell |
536,786
-212,763
| -28% | -$120M | 0.14% | 124 |
|
|
2025
Q3 | $364M | Sell |
749,549
-93,766
| -11% | -$43.6M | 0.16% | 113 |
|
|
2025
Q2 | $342M | Sell |
843,315
-182,078
| -18% | -$76.1M | 0.17% | 119 |
|
|
2025
Q1 | $510M | Buy |
1,025,393
+241,087
| +31% | +$131M | 0.26% | 61 |
|
|
2024
Q4 | $408M | Buy |
784,306
+88,895
| +13% | +$48.9M | 0.24% | 70 |
|
|
2024
Q3 | $430M | Sell |
695,411
-425,302
| -38% | -$252M | 0.25% | 70 |
|
|
2024
Q2 | $620M | Buy |
1,120,713
+103,137
| +10% | +$59.1M | 0.4% | 42 |
|
|
2024
Q1 | $591M | Buy |
1,017,576
+32,362
| +3% | +$18.2M | 0.39% | 38 |
|
|
2023
Q4 | $523M | Buy |
985,214
+174,980
| +22% | +$84.7M | 0.37% | 37 |
|
|
2023
Q3 | $410M | Buy |
810,234
+222,621
| +38% | +$119M | 0.31% | 49 |
|
|
2023
Q2 | $307M | Sell |
587,613
-178,483
| -23% | -$96.3M | 0.2% | 73 |
|
|
2023
Q1 | $442M | Buy |
766,096
+1,809
| +0.2% | +$1.02M | 0.31% | 41 |
|
|
2022
Q4 | $421M | Sell |
764,287
-45,610
| -6% | -$24.2M | 0.34% | 46 |
|
|
2022
Q3 | $411M | Buy |
809,897
+30,912
| +4% | +$17.3M | 0.29% | 48 |
|
|
2022
Q2 | $423M | Sell |
778,985
-202,958
| -21% | -$112M | 0.32% | 40 |
|
|
2022
Q1 | $580M | Buy |
981,943
+92,751
| +10% | +$53.3M | 0.35% | 31 |
|
|
2021
Q4 | $593M | Buy |
889,192
+12,601
| +1% | +$7.87M | 0.32% | 43 |
|
|
2021
Q3 | $501M | Sell |
876,591
-100,270
| -10% | -$55M | 0.3% | 44 |
|
|
2021
Q2 | $493M | Buy |
976,861
+7,106
| +0.7% | +$3.35M | 0.3% | 53 |
|
|
2021
Q1 | $443M | Buy |
969,755
+190,723
| +24% | +$91M | 0.29% | 58 |
|
|
2020
Q4 | $363M | Sell |
779,032
-86,753
| -10% | -$40.7M | 0.21% | 78 |
|
|
2020
Q3 | $382M | Buy |
865,785
+166,887
| +24% | +$68.9M | 0.25% | 58 |
|
|
2020
Q2 | $253M | Buy |
698,898
+85,151
| +14% | +$28.5M | 0.2% | 80 |
|
|
2020
Q1 | $174M | Sell |
613,747
-204,676
| -25% | -$64.5M | 0.16% | 99 |
|
|
2019
Q4 | $266M | Sell |
818,423
-91,532
| -10% | -$27.8M | 0.19% | 96 |
|
|
2019
Q3 | $265M | Sell |
909,955
-84,503
| -8% | -$24.2M | 0.21% | 75 |
|
|
2019
Q2 | $292M | Buy |
994,458
+400,388
| +67% | +$110M | 0.24% | 71 |
|
|
2019
Q1 | $163M | Buy |
594,070
+128,891
| +28% | +$32.1M | 0.16% | 110 |
|
|
2018
Q4 | $104M | Buy |
465,179
+127,036
| +38% | +$29.8M | 0.11% | 178 |
|
|
2018
Q3 | $82.5M | Sell |
338,143
-159,428
| -32% | -$36.7M | 0.07% | 236 |
|
|
2018
Q2 | $103M | Sell |
497,571
-216,105
| -30% | -$45.9M | 0.09% | 171 |
|
|
2018
Q1 | $147M | Buy |
713,676
+389,311
| +120% | +$81.7M | 0.12% | 133 |
|
|
2017
Q4 | $61.6M | Sell |
324,365
-7,310
| -2% | -$1.4M | 0.05% | 367 |
|
|
2017
Q3 | $62.8M | Buy |
331,675
+66,176
| +25% | +$12M | 0.05% | 325 |
|
|
2017
Q2 | $46.3M | Sell |
265,499
-61,374
| -19% | -$10.3M | 0.04% | 388 |
|
|
2017
Q1 | $50.2M | Buy |
326,873
+130,423
| +66% | +$19.9M | 0.04% | 359 |
|
|
2016
Q4 | $27.7M | Sell |
196,450
-63,666
| -24% | -$9.39M | 0.03% | 605 |
|
|
2016
Q3 | $41.4M | Sell |
260,116
-13,125
| -5% | -$2.02M | 0.04% | 395 |
|
|
2016
Q2 | $40.4M | Buy |
273,241
+123,017
| +82% | +$18.2M | 0.04% | 379 |
|
|
2016
Q1 | $21.3M | Sell |
150,224
-101,395
| -40% | -$13.6M | 0.02% | 574 |
|
|
2015
Q4 | $35.7M | Buy |
251,619
+149,629
| +147% | +$20M | 0.04% | 477 |
|
|
2015
Q3 | $12.5M | Sell |
101,990
-66,234
| -39% | -$8.63M | 0.01% | 996 |
|
|
2015
Q2 | $21.8M | Buy |
168,224
+40,075
| +31% | +$5.22M | 0.02% | 735 |
|
|
2015
Q1 | $17.2M | Buy |
128,149
+30,440
| +31% | +$3.92M | 0.02% | 854 |
|
|
2014
Q4 | $12.2M | Sell |
97,709
-16,578
| -15% | -$2.02M | 0.01% | 1129 |
|
|
2014
Q3 | $13.9M | Buy |
114,287
+2,093
| +2% | +$254K | 0.01% | 1040 |
|
|
2014
Q2 | $13.2M | Buy |
112,194
+900
| +0.8% | +$106K | 0.01% | 1069 |
|
|
2014
Q1 | $13.4M | Sell |
111,294
-79,863
| -42% | -$9.49M | 0.01% | 965 |
|
|
2013
Q4 | $21.3M | Sell |
191,157
-47,448
| -20% | -$4.72M | 0.02% | 734 |
|
|
2013
Q3 | $22M | Sell |
238,605
-111,226
| -32% | -$10.1M | 0.02% | 694 |
|
|
2013
Q2 | $29.6M | Buy |
+349,831
| New | +$29.1M | 0.03% | 502 |
|
Other funds holding TMO
VCM
Citigroup's TMO Position: Q1 2026 in Review
Citigroup increased its Thermo Fisher Scientific (TMO) stake by 6.6% in Q1 2026, buying an estimated $19.2M and bringing the position to 572,177 shares worth $281M. The position accounts for 0.12% of the portfolio, ranked #162.
Citigroup first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $620M in Q2 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Citigroup held 572,177 shares of Thermo Fisher Scientific worth $281M as of Q1 2026.
- Citigroup bought 35,391 Thermo Fisher Scientific shares in Q1 2026, an estimated $19.2M.
- Thermo Fisher Scientific made up 0.12% of Citigroup's portfolio in Q1 2026, its #162 holding.
- Citigroup first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Thermo Fisher Scientific position peaked at $620M in Q2 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.